Ticker | Company | Financials Score | Market Cap | ROE | ROA | ROCE | ROIC | D/E | Current Ratio | Gross Margin | Profit Margin | Operating Margin |
---|---|---|---|---|---|---|---|---|---|---|---|---|
TNET | TRINET GROUP INC | $5.25B | 116.90% | 9.60% | 37.95% | 147.70% | 26.75 | 1.06 | 21.50% | 6.80% | 9.98% | |
NGNE | NEUROGENE INC | $432.37M | -30.50% | -26.00% | -21.26% | -61.30% | 0.14 | 14.74 | N/A | N/A | N/A | |
EYPT | EYEPOINT PHARMACEUTICALS INC | $616.68M | -49.90% | -30.90% | -29.40% | 714.90% | 0.32 | 5.08 | 90.50% | -157.80% | -156.73% | |
CPA | COPA HOLDINGS SA | $4.60B | 28.40% | 10.40% | 19.63% | 14.90% | 1.45 | 0.99 | 57.80% | 14.90% | 22.25% | |
DAWN | DAY ONE BIOPHARMACEUTICALS INC | $1.41B | -57.30% | -53.30% | -70.39% | -157.80% | 0.10 | 10.93 | N/A | N/A | N/A | |
GEF | GREIF INC | $3.01B | 17.30% | 5.70% | 9.36% | 9.60% | 1.97 | 1.57 | 21.70% | 6.50% | 9.24% | |
APTO | APTOSE BIOSCIENCES INC | $19.25M | -1,003.70% | -257.60% | -7,179.76% | 1,258.40% | 92.40 | 0.97 | N/A | N/A | N/A | |
ANNX | ANNEXON INC | $400.15M | -56.50% | -46.50% | -41.50% | -102.70% | 0.16 | 20.62 | N/A | N/A | N/A | |
ACLS | AXCELIS TECHNOLOGIES INC | $3.68B | 30.20% | 20.40% | 28.16% | 33.70% | 0.45 | 4.00 | 44.60% | 22.20% | 25.69% | |
DNTH | DIANTHUS THERAPEUTICS INC | $752.23M | -21.30% | -20.30% | -11.34% | -144.70% | 0.03 | 42.52 | 100.00% | -1,878.40% | -1,878.40% | |
APGE | APOGEE THERAPEUTICS INC | $2.94B | -27.10% | -23.20% | -12.91% | -52.30% | 0.03 | 38.08 | N/A | N/A | N/A | |
SNDX | SYNDAX PHARMACEUTICALS INC | $1.72B | -53.30% | -48.50% | -48.84% | -79.30% | 0.10 | 8.93 | N/A | N/A | N/A | |
RRX | REGAL REXNORD CORP | $10.62B | -0.50% | -0.20% | 3.33% | 4.80% | 1.41 | 2.62 | 33.80% | -0.50% | 7.01% | |
IMVT | IMMUNOVANT INC | $4.46B | -61.10% | -55.30% | -35.93% | 1,380.40% | 0.05 | 22.14 | N/A | N/A | N/A |